Renalytix (RNLXY) Earnings Date & Reports

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNLXY is expected to report earnings to rise 60.00% to -7 cents per share on November 26

Q3'25

Est.

$-0.08

Q4'24

Missed

by $0.02

Q3'24

Missed

by $0.04

Q2'24

Beat

by $0.03

The last earnings report on March 18 showed earnings per share of -5 cents, missing the estimate of -2 cents. With 40.32K shares outstanding, the current market capitalization sits at 41.73M.

View a ticker or compare two or three

Compare

RNLXY

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNLXY showed earnings on March 18, 2025. You can read more about the earnings report here.

View AI-Driven Trading for RNLXY

A.I. Advisor

published General Information

General Information

Industry ServicestotheHealthIndustry

Profile

Fundamentals

Details